Candidemia clinical trials
The registry lists 73 studies for Candidemia across more than 10 countries. 5 are recruiting or about to start. 57 of them are mainly about Candidemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.
Get an email when these change. Save the Candidemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Pfizer (15) · Astellas Pharma Inc (7) · Scynexis, Inc. (3) · T2 Biosystems (3) · Basilea Pharmaceutica (3) · Assistance Publique - Hôpitaux de Paris (2) · Radboud University Medical Center (2) · Cidara Therapeutics Inc. (2)
What is being tested here
Drugs under test in Candidemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2, phase 3 first
- Sep 2027A Randomized Study of a Short Duration Therapy for Candidemia · Phase 3 · Assistance Publique - Hôpitaux de Paris
- May 2027A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia · Augusta University
Who these studies take
Of the 2 Candidemia studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 73 studies, recruiting or not: 16% stop at 75 or younger and 14% at 65; 32% take children; 0% are for women only and 0% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 12, 2026.
Newly registered1
- Middle East Study of Infections in Patients With Hematological MalignanciesOct 28, 2026NCT07900542
Studies
Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.
- Middle East Study of Infections in Patients With Hematological MalignanciesRecruitingNCT079005425 countries
- A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.RecruitingNCT05421858Phase 320 countries
- Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN TrialNot yet recruitingNCT07788586Phase 41 country
- A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated CandidemiaNot yet recruitingNCT069079921 country
- A Randomized Study of a Short Duration Therapy for CandidemiaNot yet recruitingNCT06859671Phase 3
- A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT06194201Phase 21 country
- Candida PCR Diagnosis Strategy in Patients From Intensive Care UnitsCompletedNCT04874441Not applicable1 country
- A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral FluconazoleTerminatedNCT05178862Phase 313 countries
- Safety and Efficacy of Interferon-Gamma 1b in Patients With CandidemiaCompletedNCT04979052Phase 26 countries
- Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 39 countries
- Non-Conventional Microbiological Methods in the Diagnosis of CandidemiaCompletedNCT07422155Not applicable1 country
- Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)CompletedNCT072729151 country
- An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With CandidemiaCompletedNCT03604705Phase 25 countries
- An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida AurisCompletedNCT04148287Phase 21 country
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 325 countries
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 41 country
- Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 12 countries
- Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT031744575 countries
- Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)CompletedNCT03363841Phase 34 countries
- Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 25 countries
- Comparison of Candida Eradication and Serum Cidal Activity of EchinocandinsCompletedNCT00839540Phase 41 country
- Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 318 countries
- Value of PCT When Diagnosing CandidemiaCompletedNCT053851071 country
- Genetic Susceptibility Factors for Candidemia.CompletedNCT028415011 country
- Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.Status unknownNCT036743591 country
- CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 210 countries
- Echinocandins Versus Azoles for Candidemia TreatmentCompletedNCT037991721 country
- Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole BloodStatus unknownNCT041479751 country
- Negative Beta Glucan in ICU PatientsCompletedNCT01734525Phase 41 country
- Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 310 countries
- Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IVCompletedNCT008028541 country
- Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and ToddlersCompletedNCT00797420Phase 11 country
- Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk PatientsStatus unknownNCT036521941 country
- Serial Therapeutic and Antifungal Monitoring ProtocolCompletedNCT021638891 country
- Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 28 countries
- Candida Host Defense Response After Septic Shock in the Critically IllCompletedNCT031360811 country
- A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)CompletedNCT01174147
- Bio-assay Development and Implementation for Fungal Infection DetectionWithdrawnNCT02333266
- Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With EchinocandinsTerminatedNCT01213823
- Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisTerminatedNCT00815516Phase 312 countries
- A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 31 country
- UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer PatientsWithdrawnNCT016225951 country
- A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven CandidaemiaWithdrawnNCT00509834Phase 1/21 country
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNCT00672841Not applicable1 country
- Early- and Late-onset CandidemiaCompletedNCT014060931 country
- SIHAM Candidemia Network:An Observational StudyCompletedNCT012813451 country
- Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 32 countries
- Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 315 countries
- Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 11 country
- Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)CompletedNCT015250951 country